The Rise of GLP1 Medications and their Significant Outcomes

More than 40% of Americans have obesity, a number that continues to rise. And despite being a multi-billion dollar business — the weight loss industry just isn’t helping people lose weight. Perhaps that’s why new GLP-1 medications are getting so much attention.

To learn more, I spoke to Sarah Jones Simmer, CEO of Found. With over $130M in venture funding, Found is the largest medically-supported weight care clinic in the country.

Join us as we delve into the history of the weight loss industry, and discuss how telehealth (and responsible prescribing) along with new medications, may just be an inflection point.

Visit the Heart of Healthcare website for episode recaps and more!

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.